Earnings Feed
Start Free
AMYLIN PHARMACEUTICALS INC·4

Oct 17, 2:08 PM ET

AMYLIN PHARMACEUTICALS INC 4

4 · AMYLIN PHARMACEUTICALS INC · Filed Oct 17, 2003

Insider Transaction Report

Form 4
Period: 2003-10-17
AMYLIN PHARMACEUTICALS INCAMLN
DATA JOANN L
Sr VP Regulatory Affairs & QA
Transactions
  • Sale

    Common Stock

    2003-10-17$27.61/sh−6,900$190,509→ 61,612 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2003-10-16−2,470→ 24,754 total
    Exercise: $2.50From: 2003-10-17Exp: 2009-08-11→ Common Stock (2,470 underlying)
  • Tax Payment

    Common Stock

    2003-10-16$28.40/sh−4,539$128,908→ 68,512 total
  • Exercise/Conversion

    Common Stock

    2003-10-16$2.50/sh+2,470$6,175→ 50,553 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2003-10-16−22,498→ 13,125 total
    Exercise: $5.73From: 2003-10-17Exp: 2011-10-04→ Common Stock (22,498 underlying)
  • Exercise/Conversion

    Common Stock

    2003-10-16$5.73/sh+22,498$128,914→ 73,051 total

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT